• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov24
Invivyd Inc.'s RSV Antibody Candidate VBY329 Shows Promising Preclinical Results
12:01
Nov18
Invivyd Inc Announces Public Offering of 44 Million Ordinary Shares at $2.50 Per Share and Pre-Funded Warrants
03:41
Nov6
Invivyd released FY2025 Q3 earnings on November 6 Pre-Market (EST), actual revenue USD 13.13 M (forecast USD 13.1 M), actual EPS USD -0.0615 (forecast USD -0.08)
14:30
Invivyd released FY2025 9 Months Earnings on November 6 Pre-Market EST, actual revenue USD 36.22 M, actual EPS USD -0.3195
14:30
Oct30
Invivyd to Release FY2025 Q3 Earnings on November 6 Pre-Market EST, Forecast Revenue USD 13.1 M, EPS USD -0.09
00:05
Oct28
Invivyd Inc. to Host Webinar on the Clinical Program of VYD2311
11:04

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 13.13 M, Net Income -10.47 M, EPS -0.0615

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 11.79 M, Net Income -14.66 M, EPS -0.1221

May15
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 11.3 M, Net Income -16.29 M, EPS -0.1358

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
PCSA
6.770
+125.29%
+3.750
ATPC
0.1477
+64.11%
+0.058
YCBD
2.322
+62.39%
+0.896
VYNE
0.6086
+51.13%
+0.207
ISPO
4.188
+47.47%
+1.348
MGRT
7.250
+35.51%
+1.900
GVH
3.800
+28.81%
+0.850
MDLN
37.063
+27.80%
+8.016
ANDG
20.190
+26.19%
+4.310
DBVT
22.550
+25.42%
+4.570
View More